These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4651418)

  • 21. [Mycobacterium kansasii and its variants].
    Schröder KH; Magnusson M
    Zentralbl Bakteriol Orig; 1968; 207(4):498-509. PubMed ID: 5742980
    [No Abstract]   [Full Text] [Related]  

  • 22. [Classification and identification of slowly growing atypical mycobacteria].
    Käppler W
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):31-5. PubMed ID: 4299842
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mycobacteria].
    Beer V; Bonifas V
    Schweiz Med Wochenschr; 1975 Aug; 105(31):984-7. PubMed ID: 807970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimycobacterial activity in vitro of pigments isolated from Antarctic bacteria.
    Mojib N; Philpott R; Huang JP; Niederweis M; Bej AK
    Antonie Van Leeuwenhoek; 2010 Nov; 98(4):531-40. PubMed ID: 20556653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new mycobacterium species: Mycobacterium asiaticum n. sp.
    Weiszfeiler G; Karasseva V; Karczag E
    Acta Microbiol Acad Sci Hung; 1971; 18(4):247-52. PubMed ID: 5006093
    [No Abstract]   [Full Text] [Related]  

  • 26. Differentiation between Mycobacterium kansasii and M. gastri.
    Tsukamura M
    J Gen Microbiol; 1973 Jan; 74(1):193-4. PubMed ID: 4695046
    [No Abstract]   [Full Text] [Related]  

  • 27. The susceptibility of Mycobacterium tuberculosis and atypical mycobacteria in northern Israel.
    Cahana Z; Gabbay R; Raz R
    Drugs; 1995; 49 Suppl 2():171-2. PubMed ID: 8549291
    [No Abstract]   [Full Text] [Related]  

  • 28. A system for the examination of tubercle bacilli and other mycobacteria.
    Marks J
    Tubercle; 1976 Sep; 57(3):207-25. PubMed ID: 62439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance in mycobacteria.
    Mitchison DA
    Br Med Bull; 1984 Jan; 40(1):84-90. PubMed ID: 6442876
    [No Abstract]   [Full Text] [Related]  

  • 30. [Currently used laboratory methods for testing the sensitivity and resistance of mycobacteria to drugs. Usefulness and limitations (author's transl)].
    Simon-Pouthier F
    Acta Tuberc Pneumol Belg; 1972; 63(4):399-404. PubMed ID: 4206437
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of antimicrobial agents against mycobacteria.
    Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R
    Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance to antibiotics of mycobacteria of the Province of Cadiz].
    del Rey Calero J; Casal Roman M
    Rev Sanid Hig Publica (Madr); 1971 Jan; 45(1):73-114. PubMed ID: 5006012
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibiotic sensitivity of various atypical mycobacteria in vitro].
    Atef M; Ghani MA; Niazi ZM; Youssef SA; Osman K
    Dtsch Tierarztl Wochenschr; 1982 Oct; 89(10):403-6. PubMed ID: 6756859
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria.
    Esteban J; Martín-de-Hijas NZ; García-Almeida D; Bodas-Sánchez A; Gadea I; Fernández-Roblas R
    Clin Microbiol Infect; 2009 Oct; 15(10):919-23. PubMed ID: 19438639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N
    Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relationships between "Mycobacterium simiae" and the "M. avium-intracellulare-scrofulaceum" complex (author's transl)].
    Boisvert H; Truffot C
    Ann Microbiol (Paris); 1979; 130B(4):457-66. PubMed ID: 120121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of the pigmentation of mycobacteria by the composition of medium.
    Tsukamura M
    Pneumonologie; 1970; 142(2):93-101. PubMed ID: 5497316
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.
    Sánchez-Carrillo C; Cotarelo M; Cercenado E; Vicente T; Blázquez R; Bouza E
    J Antimicrob Chemother; 1996 Jan; 37(1):151-4. PubMed ID: 8647757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
    Haas H; Michel J; Sacks TG
    Chemotherapy; 1982; 28(1):1-5. PubMed ID: 7056128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C; Gurpinar T; Ecemis T
    New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.